SC 13D

Company

Chemomab Therapeutics Ltd.

Filed

August 16, 2012

Accession Number

0001178913-12-002335

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →